$2.05
0.97% day before yesterday
Nasdaq, Aug 22, 10:00 pm CET
ISIN
US2936021086
Symbol
ENSC

Ensysce Biosciences Inc Target price 2025 - Analyst rating & recommendation

Ensysce Biosciences Inc Classifications & Recommendation:

Buy
86%
Hold
14%

Ensysce Biosciences Inc Price Target

Target Price $26.75
Price $2.05
Potential
Number of Estimates 4
4 Analysts have issued a price target Ensysce Biosciences Inc 2026 . The average Ensysce Biosciences Inc target price is $26.75. This is higher than the current stock price. The highest price target is
$35.70 1,641.46%
register free of charge
, the lowest is .
A rating was issued by 7 analysts: 6 Analysts recommend Ensysce Biosciences Inc to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Ensysce Biosciences Inc stock has an average upside potential 2026 of . Most analysts recommend the Ensysce Biosciences Inc stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 5.21 2.75
133.63% 47.14%
Net Margin -153.36% -251.47%
67.83% 63.97%

4 Analysts have issued a sales forecast Ensysce Biosciences Inc 2025 . The average Ensysce Biosciences Inc sales estimate is

$2.8m
Unlock
. This is
55.72% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$5.7m 8.84%
Unlock
, the lowest is
$0.0 100.00%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $5.2m 133.63%
2025
$2.8m 47.14%
Unlock
2026
$40.8m 1,381.48%
Unlock
2027
$89.1m 118.29%
Unlock

4 Ensysce Biosciences Inc Analysts have issued a net profit forecast 2025. The average Ensysce Biosciences Inc net profit estimate is

$-6.9m
Unlock
. This is
1.61% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-6.1m 10.12%
Unlock
, the lowest is
$-7.6m 11.29%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-8.0m 24.84%
2025
$-6.9m 13.27%
Unlock
2026
$33.7m 585.57%
Unlock

Net Margin

2024 -153.36% 67.83%
2025
-251.47% 63.97%
Unlock
2026
82.47% 132.80%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -11.45 -4.22
83.74% 63.14%
P/E negative
EV/Sales 1.19

4 Analysts have issued a Ensysce Biosciences Inc forecast for earnings per share. The average Ensysce Biosciences Inc EPS is

$-4.22
Unlock
. This is
13.17% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-3.74 23.05%
Unlock
, the lowest is
$-4.63 4.73%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-11.45 83.74%
2025
$-4.22 63.14%
Unlock
2026
$20.52 586.26%
Unlock

P/E ratio

Current -0.42 33.44%
2025
-0.49 16.17%
Unlock
2026
0.10 120.41%
Unlock

Based on analysts' sales estimates for 2025, the Ensysce Biosciences Inc stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.53 73.10%
2025
1.19 125.40%
Unlock
2026
0.08 93.25%
Unlock
2027
0.04 54.22%
Unlock

P/S ratio

Current 0.98 58.86%
2025
2.21 126.03%
Unlock
2026
0.15 93.25%
Unlock
2027
0.07 54.19%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today